A phase II study of high-dose continuous infusion interleukin-2 with lymphokine-activated killer cells in patients with metastatic melanoma

J. P. Dutcher, E. R. Gaynor, D. H. Boldt, J. H. Doroshow, M. H. Bar, M. Sznol, J. Mier, J. Sparano, R. I. Fisher, G. Weiss, K. Margolin, F. R. Aronson, M. Hawkins, M. Atkins

Research output: Contribution to journalArticle

77 Scopus citations

Fingerprint Dive into the research topics of 'A phase II study of high-dose continuous infusion interleukin-2 with lymphokine-activated killer cells in patients with metastatic melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences